Canbi Pharma Tech Limited
123441-03-2 | Rivastigmine Hydrogen Tartrate
123441-03-2 | Rivastigmine Hydrogen Tartrate
123441-03-2 | Rivastigmine Hydrogen Tartrate

123441-03-2 | Rivastigmine Hydrogen Tartrate

CAS:123441-03-2
MF:C14H22N2O2
MW:250.34
EINECS:602-936-0
MDL No.:MFCD00871496

Send Inquiry
Description

Properties

Appearance Colorless to light yellow Powder
alpha D20 -32.1° (c = 5 in ethanol)
Boiling point:316.2±34.0 °C
Density 1.038±0.06 g/cm3
Flash point:145℃
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility Chloroform (Sparingly), Ethyl Acetate (Slightly)

 

Application:

     Rivastigmine Hydrogen Tartrate is mainly used to treat mild to moderate Alzheimer's type dementia, namely suspected Alzheimer's disease or Alzheimer's disease.

English table.

Category Details
Applications

1. Mild-to-Moderate Alzheimer's Disease :dual inhibition of acetylcholinesterase/butyrylcholinesterase slows cognitive decline (memory, attention, daily function).

2. Mild-to-Moderate Dementia in Parkinson's Disease : Same formulations/dosing as Alzheimer's; improves cognitive impairment (e.g., executive function, memory) with central cholinergic enhancement.

3. Transdermal Formulation Advantage: Patch reduces GI side effects (nausea, vomiting) vs. oral; used for patients with swallowing difficulties or poor oral tolerance.4. Investigational Uses: Vascular dementia (Phase II), Lewy body dementia (clinical trials); repurposed for cognitive impairment in multiple sclerosis (preclinical).

 

KSM Synthetic Intermediates (Chemical Name, CAS No., Role)

1. (S)-3-(1-(Dimethylamino)ethyl)phenol (CAS 105601-04-5): Chiral phenol; reacts with N-ethyl-N-methylcarbamoyl chloride to form rivastigmine free base.

2. N-Ethyl-N-methylcarbamoyl chloride (CAS 42252-34-6): Carbamoylating agent; introduces the ethylmethylcarbamate group to the phenol's hydroxyl for API formation.

3. L-(+)-Tartaric Acid (CAS 87-69-4): Resolving agent; forms 1:1 rivastigmine tartrate to improve stability and solubility.

4. (R,S)-3-(1-(Dimethylamino)ethyl)phenol (Racemic Precursor, CAS 105601-04-5 racemate): Starting material; resolved via chiral acid (e.g., camphorsulfonic acid) to obtain the (S)-enantiomer.5. Rivastigmine Impurity A (Desethyl Rivastigmine, CAS 108256-02-8): Process impurity; formed by N-dealkylation (used for quality control).

 

Synonyms:

rivastigmine

123441-03-2

Exelon

Prometax

ENA 713 free base

rivastigmine hexal

(S)-Rivastigmine

Rivastigmine sandoz

(S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate

Rivastigmina

3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate

m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate

(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate

3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate

 

Hot Tags: 123441-03-2 | Rivastigmine Hydrogen Tartrate, China 123441-03-2 | Rivastigmine Hydrogen Tartrate manufacturers, suppliers, api batch processing, api augmented reality integration, api service oriented architecture, api oauth integration, api financial management api integration, api music streaming api integration

Inquiry
goTop

(0/10)

clearall